Is the level of HLA eplet mismatch a risk factor for graft loss among kidney transplant recipients who have already formed de novo donor specific antibody?

Is the level of HLA eplet mismatch a risk factor for graft loss among kidney transplant recipients who have already formed de novo donor specific antibody?

Is the level of HLA eplet mismatch a risk factor for graft loss among kidney transplant recipients who have already formed de novo donor specific antibody?

Eplet mismatches are related to de novo DSA (dnDSA) and antibody mediated rejection (ABMR) among the many common kidney transplant inhabitants. Nevertheless, it’s unclear whether or not the extent of eplet mismatch can be utilized for threat stratification amongst sufferers with dnDSA. We carried out a retrospective observational research of kidney transplant recipients with dnDSA (n = 44) transplanted between 10/2007 and 5/2014 to guage eplet mismatch as a threat issue for ABMR and allograft loss amongst dnDSA sufferers.

Excessive decision typing was inferred from by imputation primarily based on ethnicity and NMDP haplotypes, and the eplet mismatch was calculated utilizing the Epvix algorithm. Biopsies (N = 151) from 95.3%(42/44) of sufferers had been reviewed. The imply (SD) eplet mismatch was 69.8(22.8). The ABMR incidence was 71.4% (30/42) and 5 yr loss of life censored allograft survival was 67.4% throughout the imply (SD) follow-up of 5.3 (3.1) years. ABMR and death-censored allograft survival weren’t correlated with eplet mismatch amongst dnDSA sufferers.

Nevertheless, treatment adherence and dnDSA MFI < 3000 had been related to decreased ABMR incidence. Amongst sufferers with each of those favorable traits, solely 35.7% (15/42) developed ABMR. In conclusion, the extent of eplet mismatch doesn’t correlate with ABMR or allograft loss amongst excessive threat kidney transplant sufferers with dnDSA.

Excessive-throughput screening and validation of antibodies in opposition to synaptic proteins to discover opioid signaling dynamics

Antibodies symbolize highly effective instruments to look at sign transduction pathways. Right here, we current a technique integrating a number of state-of-the-art strategies to supply, validate, and make the most of antibodies. Specializing in understudied synaptic proteins, we generated 137 recombinant antibodies. We used yeast show antibody libraries from the B cells of immunized rabbits, adopted by FACS sorting beneath stringent circumstances to establish excessive affinity antibodies. The antibodies had been validated by high-throughput useful screening, and genome enhancing. Subsequent, we explored the temporal dynamics of signaling in single cells.
A subset of antibodies concentrating on opioid receptors had been used to look at the impact of therapy with opiates which have performed central roles within the worsening of the ‘opioid epidemic.’ We present that morphine and fentanyl exhibit differential temporal dynamics of receptor phosphorylation. In abstract, high-throughput approaches can result in the identification of antibody-based instruments required for an in-depth understanding of the temporal dynamics of opioid signaling.

SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies

Extreme Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) transmission is uncontrolled in lots of components of the world, compounded in some areas by increased transmission potential of the B1.1.7 variant now seen in 50 nations. It’s unclear whether or not responses to SARS-CoV-2 vaccines primarily based on the prototypic pressure will likely be impacted by mutations present in B.1.1.7. Right here we assessed immune responses following vaccination with mRNA-based vaccine BNT162b2. We measured neutralising antibody responses following a single immunization utilizing pseudoviruses expressing the wild-type Spike protein or the Eight amino acid mutations discovered within the B.1.1.7 spike protein.
The vaccine sera exhibited a broad vary of neutralising titres in opposition to the wild-type pseudoviruses that had been modestly decreased in opposition to B.1.1.7 variant. This discount was additionally evident in sera from some convalescent sufferers. Decreased B.1.1.7 neutralisation was additionally noticed with monoclonal antibodies concentrating on the N-terminal area (9 out of 10), the Receptor Binding Motif (RBM) (5 out of 31), however not in neutralising mAbs binding outdoors the RBM. Introduction of the E484Ok mutation in a B.1.1.7 background to replicate newly rising viruses within the UK led to a extra substantial lack of neutralising exercise by vaccine-elicited antibodies and mAbs (19 out of 31) over that conferred by the B.1.1.7 mutations alone. E484Ok emergence on a B.1.1.7 background represents a risk to the vaccine BNT162b.
Is the level of HLA eplet mismatch a risk factor for graft loss among kidney transplant recipients who have already formed de novo donor specific antibody?

Decreased neutralization of SARS-CoV-2 international variants by therapeutic anti-spike protein monoclonal antibodies

Monoclonal antibodies in opposition to the SARS-CoV-2 spike protein, notably, these developed by Regeneron Prescribed drugs and Eli Lilly and Firm have confirmed to supply safety in opposition to extreme COVID-19. The emergence of SARS-CoV-2 variants with closely mutated spike proteins raises the priority that the remedy might develop into much less efficient if any of the mutations disrupt epitopes engaged by the antibodies.
On this research, we examined monoclonal antibodies REGN10933 and REGN10987 which are utilized in mixture, for his or her capability to neutralize SARS-CoV-2 variants B.1.1.7, B.1.351, mink cluster 5 and COH.20G/677H. We report that REGN10987 maintains most of its neutralization exercise in opposition to viruses with B.1.1.7, B.1.351 and mink cluster 5 spike proteins however that REGN10933 has misplaced exercise in opposition to B.1.351 and mink cluster 5.
The failure of REGN10933 to neutralize B.1.351 is attributable to the Ok417N and E484Ok mutations within the receptor binding area; the failure to neutralize the mink cluster 5 spike protein is attributable to the Y453F mutation. The REGN10933 and REGN10987 mixture was 9.1-fold much less potent on B.1.351 and 16.2-fold much less potent on mink cluster 5, elevating considerations of decreased efficacy within the therapy of sufferers contaminated with variant viruses.

PLGF(PLGF93) Antibody
BNC800093-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF93), CF680 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC800094-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF94), CF680 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC800094-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF94), CF680 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC810093-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF93), CF680R conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC810093-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF93), CF680R conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC810094-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF94), CF680R conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC810094-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF94), CF680R conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC940093-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF93), CF594 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC940093-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF93), CF594 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC940094-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF94), CF594 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC940094-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF94), CF594 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC880093-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF93), CF488A conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC880093-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF93), CF488A conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC880094-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF94), CF488A conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC880094-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF94), CF488A conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC430093-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF93), CF543 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC430093-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF93), CF543 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC430094-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF94), CF543 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC430094-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF94), CF543 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC400093-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF93), CF640R conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC400093-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF93), CF640R conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC400094-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF94), CF640R conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC400094-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF94), CF640R conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC050093-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF93), CF405M conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC050093-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF93), CF405M conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC050094-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF94), CF405M conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC050094-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF94), CF405M conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNCB0093-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF93), Biotin conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNCB0093-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF93), Biotin conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNCB0094-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF94), Biotin conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNCB0094-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF94), Biotin conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNCAP0093-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF93), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNCAP0093-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF93), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNCAP0094-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF94), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNCAP0094-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF94), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNCR0093-250 250uL
EUR 459.6
Description: Primary antibody against PLGF(PLGF93), RPE conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNCR0094-250 250uL
EUR 459.6
Description: Primary antibody against PLGF(PLGF94), RPE conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNUB0093-100 100uL
EUR 250.8
Description: Primary antibody against PLGF(PLGF93), Concentration: 0.2mg/mL

PLGF(PLGF93) Antibody
BNUB0093-500 500uL
EUR 549.6
Description: Primary antibody against PLGF(PLGF93), Concentration: 0.2mg/mL

PLGF(PLGF94) Antibody
BNUB0094-100 100uL
EUR 250.8
Description: Primary antibody against PLGF(PLGF94), Concentration: 0.2mg/mL

PLGF(PLGF94) Antibody
BNUB0094-500 500uL
EUR 549.6
Description: Primary antibody against PLGF(PLGF94), Concentration: 0.2mg/mL

PLGF(PLGF93) Antibody
BNCP0093-250 250uL
EUR 459.6
Description: Primary antibody against PLGF(PLGF93), PerCP conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNCP0094-250 250uL
EUR 459.6
Description: Primary antibody against PLGF(PLGF94), PerCP conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNUM0093-50 50uL
EUR 474
Description: Primary antibody against PLGF(PLGF93), 1mg/mL

PLGF(PLGF94) Antibody
BNUM0094-50 50uL
EUR 474
Description: Primary antibody against PLGF(PLGF94), 1mg/mL

PLGF(PLGF93) Antibody
BNCH0093-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF93), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNCH0093-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF93), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNCH0094-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF94), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNCH0094-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF94), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC040093-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF93), CF405S conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC040093-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF93), CF405S conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC040094-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF94), CF405S conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC040094-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF94), CF405S conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC550093-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF93), CF555 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC550093-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF93), CF555 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC550094-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF94), CF555 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC550094-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF94), CF555 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC610093-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF93), CF660R conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC610093-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF93), CF660R conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC610094-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF94), CF660R conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC610094-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF94), CF660R conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC680093-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF93), CF568 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC680093-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF93), CF568 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC680094-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF94), CF568 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC680094-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF94), CF568 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC470093-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF93), CF647 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC470093-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF93), CF647 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC470094-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF94), CF647 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC470094-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF94), CF647 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC700093-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF93), CF770 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF93) Antibody
BNC700093-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF93), CF770 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC700094-100 100uL
EUR 238.8
Description: Primary antibody against PLGF(PLGF94), CF770 conjugate, Concentration: 0.1mg/mL

PLGF(PLGF94) Antibody
BNC700094-500 500uL
EUR 652.8
Description: Primary antibody against PLGF(PLGF94), CF770 conjugate, Concentration: 0.1mg/mL

PlGF Antibody
5743-100 each
EUR 405.6

PlGF Antibody
5743-30T each
EUR 175.2

PLGF Antibody
49602-100ul 100ul
EUR 399.6

PLGF Antibody
49602-50ul 50ul
EUR 286.8

PlGF antibody
70R-12427 100 ug
EUR 523.2
Description: Rabbit polyclonal PlGF antibody

PLGF Antibody
R34945-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: Placental growth factor; PGF

PLGF Antibody
R30247 100 ug
EUR 356.15
Description: Placental growth factor(PGF, also known as PLGF) codes for an angiogenic factor expressed in placental tissue that is similar to vascular permeability factor/vascular endothelial growth factor(VPF/VEGF). It is a glycosylated dimeric secreted protein able to stimulate endothelial cell growth in vitro. PGF is located on chromosome 14 and has been conserved in evolution. It belongs to the family of vascular endothelial growth factors(VEGFs) and binds to the flt-1 VEGF receptor. PLGF-2, which is a PLGF isoform, binds neuropilin-1 and 2 in a heparin-dependent manner. PGF regulates inter- and intra molecular cross talk between the VEGF RTKs Flt1 and Flk1 and stimulates the phosphorylation of specific Flt1 tyrosine residues and the expression of distinct downstream target genes. Moreover, it plays an important role in pathological angiogenic events and with exerting its biological activities through binding to VEGFR1.

PlGF-1 Antibody
5739-100 each
EUR 405.6

PlGF-1 Antibody
5739-30T each
EUR 175.2

Mouse Placenta Growth Factor (PLGF) Protein
20-abx068553
  • EUR 1178.40
  • EUR 410.40
  • EUR 3834.00
  • EUR 1412.40
  • EUR 811.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Growth Factor (PLGF) Polyclonal Antibody (Mouse)
4-PAA114Mu01
  • EUR 228.00
  • EUR 1934.40
  • EUR 505.20
  • EUR 273.60
  • EUR 226.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Placenta Growth Factor (PLGF)

Mouse placenta growth factor,PLGF ELISA kit
CN-02373M1 96T
EUR 565.2

Mouse placenta growth factor,PLGF ELISA kit
CN-02373M2 48T
EUR 386.4

Mouse Placenta Growth Factor (PLGF) ELISA Kit
DLR-PLGF-Mu-48T 48T
EUR 380.4
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Placenta Growth Factor (PLGF) in samples from serum, plasma, tissue homogenates or other biological fluids.

Mouse Placenta Growth Factor (PLGF) ELISA Kit
DLR-PLGF-Mu-96T 96T
EUR 477.6
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Placenta Growth Factor (PLGF) in samples from serum, plasma, tissue homogenates or other biological fluids.

Mouse placenta growth factor, PLGF ELISA kit
CSB-E07401m-24T 1 plate of 24 wells
EUR 198
Description: Quantitativecompetitive ELISA kit for measuring Mouse placenta growth factor, PLGF in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Mouse placenta growth factor, PLGF ELISA kit
1-CSB-E07401m
  • EUR 867.60
  • EUR 5859.60
  • EUR 3109.20
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitativecompetitive ELISA kit for measuring Mouse placenta growth factor, PLGF in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Mouse placenta growth factor(PLGF)ELISA Kit 　
GA-E0088MS-48T 48T
EUR 403.2

Mouse placenta growth factor(PLGF)ELISA Kit 　
GA-E0088MS-96T 96T
EUR 640.8

Mouse Placenta growth factor, PlGF ELISA Kit
ELA-E0114m 96 Tests
EUR 1038

Mouse Placenta Growth Factor (PLGF) ELISA Kit
RD-PLGF-Mu-48Tests 48 Tests
EUR 354

Mouse Placenta Growth Factor (PLGF) ELISA Kit
RD-PLGF-Mu-96Tests 96 Tests
EUR 480

Mouse Placenta Growth Factor (PLGF) ELISA Kit
RDR-PLGF-Mu-48Tests 48 Tests
EUR 368.4

Mouse Placenta Growth Factor (PLGF) ELISA Kit
RDR-PLGF-Mu-96Tests 96 Tests
EUR 501.6

Mouse placenta growth factor(PLGF)ELISA Kit
QY-E21188 96T
EUR 433.2

Mouse Placenta Growth Factor (PLGF) ELISA Kit
SEA114Mu-10x96wellstestplate 10x96-wells test plate
EUR 4091.29
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Placenta Growth Factor (PLGF) in serum, plasma, tissue homogenates and other biological fluids.

Mouse Placenta Growth Factor (PLGF) ELISA Kit
SEA114Mu-1x48wellstestplate 1x48-wells test plate
EUR 442.1
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Placenta Growth Factor (PLGF) in serum, plasma, tissue homogenates and other biological fluids.

Mouse Placenta Growth Factor (PLGF) ELISA Kit
SEA114Mu-1x96wellstestplate 1x96-wells test plate
EUR 580.15
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Placenta Growth Factor (PLGF) in serum, plasma, tissue homogenates and other biological fluids.

Mouse Placenta Growth Factor (PLGF) ELISA Kit
SEA114Mu-5x96wellstestplate 5x96-wells test plate
EUR 2250.68
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Placenta Growth Factor (PLGF) in serum, plasma, tissue homogenates and other biological fluids.

Mouse Placenta Growth Factor (PLGF) ELISA Kit
4-SEA114Mu
  • EUR 4152.00
  • EUR 2191.20
  • EUR 580.80
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Mouse Placenta Growth Factor (PLGF) in samples from Serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species.

Mouse placenta growth factor,PLGF ELISA kit 　
YLA0480MO-48T 48T
EUR 465

Mouse placenta growth factor,PLGF ELISA kit 　
YLA0480MO-96T 96T
EUR 600

Mouse Placenta Growth Factor (PLGF) ELISA Kit
RDR-PLGF-Mu-48T 48T
EUR 247.49
Description: serum, plasma, tissue homogenates and other biological fluids.

Mouse Placenta Growth Factor (PLGF) ELISA Kit
RDR-PLGF-Mu-96T 96T
EUR 353.54
Description: serum, plasma, tissue homogenates and other biological fluids.

Mouse Placenta Growth Factor (PLGF) ELISA Kit
RD-PLGF-Mu-48T 48T
EUR 235.7
Description: serum, plasma, tissue homogenates and other biological fluids.

Mouse Placenta Growth Factor (PLGF) ELISA Kit
RD-PLGF-Mu-96T 96T
EUR 336.7
Description: serum, plasma, tissue homogenates and other biological fluids.

Placenta Growth Factor (PLGF) Polyclonal Antibody (Mouse), PE
4-PAA114Mu01-PE
  • EUR 273.60
  • EUR 1992.00
  • EUR 606.00
  • EUR 328.80
  • EUR 199.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Placenta Growth Factor (PLGF). This antibody is labeled with PE.

Placenta Growth Factor (PLGF) Polyclonal Antibody (Mouse), APC
4-PAA114Mu01-APC
  • EUR 312.00
  • EUR 2461.20
  • EUR 727.20
  • EUR 380.40
  • EUR 218.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Placenta Growth Factor (PLGF). This antibody is labeled with APC.

Placenta Growth Factor (PLGF) Polyclonal Antibody (Mouse), Cy3
4-PAA114Mu01-Cy3
  • EUR 366.00
  • EUR 3231.60
  • EUR 920.40
  • EUR 457.20
  • EUR 241.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Placenta Growth Factor (PLGF). This antibody is labeled with Cy3.

Placenta Growth Factor (PLGF) Polyclonal Antibody (Mouse), HRP
4-PAA114Mu01-HRP
  • EUR 290.40
  • EUR 2152.80
  • EUR 650.40
  • EUR 349.20
  • EUR 208.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Placenta Growth Factor (PLGF). This antibody is labeled with HRP.

PLGF protein
30R-2693 10 ug
EUR 390
Description: Purified recombinant Mouse PLGF protein

PLGF Peptide
42-184P 0.1 mg
EUR 405.6
Description: (IN) PLGF Peptide

Placenta Growth Factor (PLGF) Polyclonal Antibody (Mouse), FITC
4-PAA114Mu01-FITC
  • EUR 273.60
  • EUR 1992.00
  • EUR 606.00
  • EUR 328.80
  • EUR 199.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Placenta Growth Factor (PLGF). This antibody is labeled with FITC.

ELISA kit for Mouse PLGF (Placenta Growth Factor)
ELK1242 1 plate of 96 wells
EUR 446.4
Description: A sandwich ELISA kit for detection of Placenta Growth Factor from Mouse in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Polyclonal PlGF Antibody
AMR09382G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PlGF . This antibody is tested and proven to work in the following applications:

PLGF Conjugated Antibody
C49602 100ul
EUR 476.4

PLGF Polyclonal Antibody
A72122
  • EUR 302.50
  • EUR 423.50
  • 50 ul
  • 100 ul

PLGF Polyclonal Antibody
A72123
  • EUR 302.50
  • EUR 423.50
  • 50 ul
  • 100 ul

Polyclonal PlGF-1 Antibody
AMR09383G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PlGF-1 . This antibody is tested and proven to work in the following applications:

Placenta Growth Factor (PLGF) Polyclonal Antibody (Mouse), Biotinylated
4-PAA114Mu01-Biotin
  • EUR 298.80
  • EUR 1874.40
  • EUR 603.60
  • EUR 349.20
  • EUR 230.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Placenta Growth Factor (PLGF). This antibody is labeled with Biotin.

ELISA kit for Mouse Placenta growth factor (PLGF)
KTE70764-48T 48T
EUR 457.2
Description: Quantitative sandwich ELISA for measuring Mouse Placenta growth factor (PLGF) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Mouse Placenta growth factor (PLGF)
KTE70764-5platesof96wells 5 plates of 96 wells
EUR 3194.4
Description: Quantitative sandwich ELISA for measuring Mouse Placenta growth factor (PLGF) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Mouse Placenta growth factor (PLGF)
KTE70764-96T 96T
EUR 802.8
Description: Quantitative sandwich ELISA for measuring Mouse Placenta growth factor (PLGF) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Placenta Growth Factor (PLGF) Polyclonal Antibody (Mouse), APC-Cy7
4-PAA114Mu01-APC-Cy7
  • EUR 480.00
  • EUR 4778.40
  • EUR 1311.60
  • EUR 618.00
  • EUR 294.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Placenta Growth Factor (PLGF). This antibody is labeled with APC-Cy7.

PLGF Rabbit pAb
A16257-100ul 100 ul
EUR 369.6

PLGF Rabbit pAb
A16257-200ul 200 ul
EUR 550.8

PLGF Rabbit pAb
A16257-20ul 20 ul
EUR 219.6

PLGF Rabbit pAb
A16257-50ul 50 ul
EUR 267.6

PLGF Rabbit pAb
A1727-100ul 100 ul
EUR 369.6

PLGF Rabbit pAb
A1727-200ul 200 ul
EUR 550.8

PLGF Rabbit pAb
A1727-20ul 20 ul
EUR 219.6

PLGF Rabbit pAb
A1727-50ul 50 ul
EUR 267.6

PLGF-1, human recombinant
4739-100 each
EUR 836.4

PLGF-1, human recombinant
4739-1000 each
EUR 3909.6

PLGF-1, human recombinant
4739-25 each
EUR 307.2

PLGF-2, human recombinant
4741-10 each
EUR 307.2

PLGF-2, human recombinant
4741-1000 each
EUR 4105.2

PLGF-2, human recombinant
4741-50 each
EUR 874.8

PLGF-3 Human Recombinant
P1563-10 10 µg
EUR 211.2

PLGF-3 Human Recombinant
P1563-50 50 µg
EUR 661.2

PLGF, murine recombinant
4743-10 each
EUR 294

PLGF, murine recombinant
4743-1000 each
EUR 6519.6

PLGF, murine recombinant
4743-50 each
EUR 907.2

PlGF Recombinant Protein
96-625 0.02 mg
EUR 651.3
Description: Placental growth factor (PGF) is also known as vascular endothelial growth factor-related protein, PLGF and PlGF2, is a member of the VEGF (vascular endothelial growth factor) sub-family - a key molecule in angiogenesis and vasculogenesis, in particular during embryogenesis. The main source of PGF during pregnancy is the placental trophoblast. PGF is also expressed in many other tissues, including the villous trophoblast. PGF is actived in angiogenesis and endothelial cell growth, stimulating their proliferation and migration. PlGF2 binds NRP1/neuropilin-1 and NRP2/neuropilin-2 in a heparin-dependent manner. Also promotes cell tumor growth.

PlGF-1 Recombinant Protein
40-151-0005mg 0.005 mg
EUR 311.1
Description: PlGF-1 is an angiogenic factor that belongs to the cysteine-knot superfamily of growth factors. PlGF-1 is expressed in placental tissues, colon and mammary carcinomas. It signals through the VEGFR-1/FLT1 receptor and stimulates endothelial cell proliferation and migration. Recombinant human PlGF-1 is a 29.7 kDa disulfide-linked homodimeric protein of two 131 amino acid polypeptide chains.

PlGF-1 Recombinant Protein
40-151-0025mg 0.025 mg
EUR 437.1
Description: PlGF-1 is an angiogenic factor that belongs to the cysteine-knot superfamily of growth factors. PlGF-1 is expressed in placental tissues, colon and mammary carcinomas. It signals through the VEGFR-1/FLT1 receptor and stimulates endothelial cell proliferation and migration. Recombinant human PlGF-1 is a 29.7 kDa disulfide-linked homodimeric protein of two 131 amino acid polypeptide chains.

PlGF-2 Recombinant Protein
40-196-0005mg 0.005 mg
EUR 311.1
Description: PLGF-2 is an angiogenic factor that belongs to the cysteine-knot superfamily of growth factors. PLGF-2 is expressed in umbilical vein endothelial cells and placenta. It signals through the VEGFR-1/FLT1 receptor and stimulates endothelial cell proliferation and migration. PlGF-2 also signals through Neuropilin (NP-1) and can bind with high affinity to heparin. Recombinant human PLGF-2 is a 34.0 kDa disulfide-linked homodimeric protein of two 150 amino acid polypeptide chains.

PlGF-2 Recombinant Protein
40-196-0025mg 0.025 mg
EUR 437.1
Description: PLGF-2 is an angiogenic factor that belongs to the cysteine-knot superfamily of growth factors. PLGF-2 is expressed in umbilical vein endothelial cells and placenta. It signals through the VEGFR-1/FLT1 receptor and stimulates endothelial cell proliferation and migration. PlGF-2 also signals through Neuropilin (NP-1) and can bind with high affinity to heparin. Recombinant human PLGF-2 is a 34.0 kDa disulfide-linked homodimeric protein of two 150 amino acid polypeptide chains.

PlGF-3 Recombinant Protein
40-197-0005mg 0.005 mg
EUR 311.1
Description: PlGF-3 is an angiogenic factor that belongs to the cysteine-knot superfamily of growth factors. PlGF-3 is expressed exclusively in the placenta. It signals through the VEGFR-1/FLT1 receptor and stimulates endothelial cell proliferation and migration. PlGF-3 lacks heparin binding affinity. Recombinant human PlGF-3 is a 45.7 kDa disulfide-linked homodimeric protein of two 203 amino acid polypeptide chains.

PlGF-3 Recombinant Protein
40-197-0025mg 0.025 mg
EUR 437.1
Description: PlGF-3 is an angiogenic factor that belongs to the cysteine-knot superfamily of growth factors. PlGF-3 is expressed exclusively in the placenta. It signals through the VEGFR-1/FLT1 receptor and stimulates endothelial cell proliferation and migration. PlGF-3 lacks heparin binding affinity. Recombinant human PlGF-3 is a 45.7 kDa disulfide-linked homodimeric protein of two 203 amino acid polypeptide chains.

PlGF-1 Recombinant Protein
40-529 0.025 mg
EUR 481.2
Description: PlGF-1 is an angiogenic factor that belongs to the cysteine-knot superfamily of growth factors. PlGF-1 is expressed in placental tissues, colon and mammary carcinomas. It signals through the VEGFR-1/FLT1 receptor and stimulates endothelial cell proliferation and migration. Recombinant human PlGF-1 is a 29.7 kDa disulfide-linked homodimeric protein of two 131 amino acid polypeptide chains.

PLGF-1 Recombinant Protein
40-707 5 ug
EUR 311.1
Description: PlGF-1 is an angiogenic factor that belongs to the cysteine-knot superfamily of growth factors. PlGF-1 is expressed in placental tissues, the colon, and mammary carcinomas. It signals through the VEGFR-1/FLT1 receptor, and stimulates endothelial cell proliferation and migration. Recombinant Rat PlGF-1 is a 30.3 kDa disulfide-linked homodimeric protein of two 135 amino acid polypeptide chains.

Rat PLGF ELISA Kit
ERP0025 96Tests
EUR 625.2

Monoclonal PLGF (Placental Growth Factor) Antibody - With BSA and Azide, Clone: PLGF/93
AMP00014G 0.05mg
EUR 475.2
Description: A Monoclonal antibody against Human PLGF (Placental Growth Factor) - With BSA and Azide. The antibodies are raised in Mouse and are from clone PLGF/93. This antibody is applicable in E

Goat PLGF ELISA Kit
EGTP0025 96Tests
EUR 625.2

Sheep PLGF ELISA Kit
ESP0025 96Tests
EUR 625.2

Human PLGF ELISA kit
LF-EK50333 1×96T
EUR 777.6

PLGF ELISA KIT|Human
EF000015 96 Tests
EUR 826.8

Human PLGF ELISA Kit
EHP0025 96Tests
EUR 625.2

Monoclonal PLGF (Placental Growth Factor) Antibody - Without BSA and Azide, Clone: PLGF/93
APR07448G 0.1mg
EUR 580.8
Description: A Monoclonal antibody against Human PLGF (Placental Growth Factor) - Without BSA and Azide. The antibodies are raised in Mouse and are from clone PLGF/93. This antibody is applicable in E

Monoclonal PLGF (Placental Growth Factor) Antibody - Without BSA and Azide, Clone: PLGF/94
APR07449G 0.1mg
EUR 580.8
Description: A Monoclonal antibody against Human PLGF (Placental Growth Factor) - Without BSA and Azide. The antibodies are raised in Mouse and are from clone PLGF/94. This antibody is applicable in E

Rabbit PLGF ELISA Kit
ERTP0025 96Tests
EUR 625.2

Monkey PLGF ELISA Kit
EMKP0025 96Tests
EUR 625.2

Bovine PLGF ELISA Kit
EBP0025 96Tests
EUR 625.2

Canine PLGF ELISA Kit
ECP0025 96Tests
EUR 625.2

Porcine PLGF ELISA Kit
EPP0025 96Tests
EUR 625.2

Chicken PLGF ELISA Kit
ECKP0025 96Tests
EUR 625.2

Anserini PLGF ELISA Kit
EAP0025 96Tests
EUR 625.2

Placenta Growth Factor (PLGF) Antibody
20-abx174070
  • EUR 844.80
  • EUR 427.20
  • 1 mg
  • 200 ug

Placenta Growth Factor (PLGF) Antibody
20-abx174071
  • EUR 1011.60
  • EUR 526.80
  • 1 mg
  • 200 ug

Placenta Growth Factor (PLGF) Antibody
20-abx178023
  • EUR 1362.00
  • EUR 661.20
  • 1 mg
  • 200 ug

Placenta Growth Factor (PLGF) Antibody
20-abx178024
  • EUR 1545.60
  • EUR 744.00
  • 1 mg
  • 200 ug

Placenta Growth Factor (PLGF) Antibody
20-abx102283
  • EUR 360.00
  • EUR 159.60
  • EUR 961.20
  • EUR 510.00
  • EUR 309.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Growth Factor (PLGF) Antibody
20-abx102284
  • EUR 376.80
  • EUR 159.60
  • EUR 1028.40
  • EUR 526.80
  • EUR 326.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Growth Factor (PLGF) Antibody
20-abx102285
  • EUR 510.00
  • EUR 159.60
  • EUR 1412.40
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Growth Factor (PLGF) Antibody
abx433146-200ul 200 ul
EUR 460.8

Placenta Growth Factor (PLGF) Antibody
20-abx142140
  • EUR 444.00
  • EUR 727.20
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 50 ul

Recombinant Human PlGF-3 Protein
PROTP49763-6 25ug
EUR 380.4
Description: PlGF-3 is an angiogenic factor that belongs to the cysteine-knot superfamily of growth factors. PlGF-3 is expressed exclusively in the placenta. It signals through the VEGFR-1/FLT1 receptor and stimulates endothelial cell proliferation and migration. PlGF-3 lacks heparin binding affinity. Recombinant human PlGF-3 is a 45.7 kDa disulfide-linked homodimeric protein of two 203 amino acid polypeptide chains.

Recombinant Human PlGF-1 Protein
PROTP49763-7 25ug
EUR 380.4
Description: PlGF-1 is an angiogenic factor that belongs to the cysteine-knot superfamily of growth factors. PlGF-1 is expressed in placental tissues, colon and mammary carcinomas. It signals through the VEGFR-1/FLT1 receptor and stimulates endothelial cell proliferation and migration. Recombinant human PlGF-1 is a 29.7 kDa disulfide-linked homodimeric protein of two 132 amino acid polypeptide chains.

Recombinant Human PlGF-2 Protein
PROTP49763-8 25ug
EUR 380.4
Description: PLGF-2 is an angiogenic factor that belongs to the cysteine-knot superfamily of growth factors. PLGF-2 is expressed in umbilical vein endothelial cells and placenta. It signals through the VEGFR-1/FLT1 receptor and stimulates endothelial cell proliferation and migration. PlGF-2 also signals through Neuropilin (NP-1) and can bind with high affinity to heparin. Recombinant human PLGF-2 is a 34.0 kDa disulfide-linked homodimeric protein of two 150 amino acid polypeptide chains.

PLGF-2, human recombinant protein
P1056-.01 10 µg
EUR 360
Description: Placenta Growth Factor-2 (PLGF-2) is an angiogenic factor produced in umbilical vein endothelial cells and placenta. PLGF-2 plays important roles in angiogenesis and endothelial cell growth.

PLGF-2, human recombinant protein
P1056-.05 50 µg
EUR 1052.4
Description: Placenta Growth Factor-2 (PLGF-2) is an angiogenic factor produced in umbilical vein endothelial cells and placenta. PLGF-2 plays important roles in angiogenesis and endothelial cell growth.

PLGF-2, human recombinant protein
P1056-1 1 mg
EUR 4987.2
Description: Placenta Growth Factor-2 (PLGF-2) is an angiogenic factor produced in umbilical vein endothelial cells and placenta. PLGF-2 plays important roles in angiogenesis and endothelial cell growth.

PLGF / PGF Recombinant Protein
11-459 0.05 mg
EUR 714.3
Description: Placental growth factor (PGF) is also known as vascular endothelial growth factor-related protein, PLGF and PlGF2, is a member of the VEGF (vascular endothelial growth factor) sub-family - a key molecule in angiogenesis and vasculogenesis, in particular during embryogenesis. The main source of PGF during pregnancy is the placental trophoblast. PGF is also expressed in many other tissues, including the villous trophoblast. PGF is actived in angiogenesis and endothelial cell growth, stimulating their proliferation and migration. PlGF2 binds NRP1/neuropilin-1 and NRP2/neuropilin-2 in a heparin-dependent manner. Also promotes cell tumor growth.

ELISA kit for Human PLGF
EK5213 96 tests
EUR 663.6
Description: Enzyme-linked immunosorbent assay kit for quantification of Human PLGF in samples from serum, plasma, tissue homogenates and other biological fluids.

Guinea Pig PLGF ELISA Kit
EGP0025 96Tests
EUR 625.2

Plgf Antibody / Pgf / Placenta growth factor
R32889 100 ug
EUR 356.15
Description: Placenta growth factor (PGF, also known as PLGF) codes for an angiogenic factor expressed in placental tissue that is similar to vascular permeability factor/vascular endothelial growth factor (VPF/VEGF). It is a glycosylated dimeric secreted protein able to stimulate endothelial cell growth in vitro. PGF is located on chromosome 14 and has been conserved in evolution. It belongs to the family of vascular endothelial growth factors (VEGFs) and binds to the flt-1 VEGF receptor. PLGF-2, which is a PLGF isoform, binds neuropilin-1 and 2 in a heparin-dependent manner. PGF regulates inter- and intra molecular cross talk between the VEGF RTKs Flt1 and Flk1 and stimulates the phosphorylation of specific Flt1 tyrosine residues and the expression of distinct downstream target genes. Moreover, it plays an important role in pathological angiogenic events and with exerting its biological activities through binding to VEGFR1.

PLGF Antibody / PGF / Placenta Growth Factor
RQ4653 100ug
EUR 356.15
Description: Placental growth factor (PGF, also known as PLGF) codes for an angiogenic factor expressed in placental tissue that is similar to vascular permeability factor/vascular endothelial growth factor (VPF/VEGF). It is a glycosylated dimeric secreted protein able to stimulate endothelial cell growth in vitro. PGF is located on chromosome 14 and has been conserved in evolution. It belongs to the family of vascular endothelial growth factors (VEGFs) and binds to the flt-1 VEGF receptor. PLGF-2, which is a PLGF isoform, binds neuropilin-1 and 2 in a heparin-dependent manner. PGF regulates inter- and intra molecular cross talk between the VEGF RTKs Flt1 and Flk1 and stimulates the phosphorylation of specific Flt1 tyrosine residues and the expression of distinct downstream target genes. Moreover, it plays an important role in pathological angiogenic events and with exerting its biological activities through binding to VEGFR1.

PLGF Antibody / PGF / Placenta Growth Factor
V3161-100UG 100 ug
EUR 349.3
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include Fibroblast Growth Factor (FGF), Platelet Derived Growth Factor (PDGF), Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PLGF). Placenta growth factor (PLGF) is a secreted protein primarily produced by placental trophoblasts but also expressed in other endothelial cells and tumors. There are three isoforms, PLGF-1, PLGF-2, and PLGF-3. PLGF-2 is expressed up until week 8 in the placenta; the placental tissues continuously express PLGF-1 and PLGF-3 but only PLGF-1 is found in colon and mammary carcinomas. PLGF acts to stimulate angiogenesis, endothelial growth and migration. PLGF is a powerful promoter of tumor growth and is upregulated in some cancers, and PLGF is thought to aid in atherosclerotic lesions and neovascular growth surrounding the lesion. Also, PLGF appears to aid aldosterone mediated atherosclerosis. Serum levels of PLGF in some cases are used as a potential biomarker for disease or genetic defect. Recent research indicates that PLGF levels are lower in mothers with Down syndrome fetuses. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor
V3161-20UG 20 ug
EUR 153.3
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include Fibroblast Growth Factor (FGF), Platelet Derived Growth Factor (PDGF), Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PLGF). Placenta growth factor (PLGF) is a secreted protein primarily produced by placental trophoblasts but also expressed in other endothelial cells and tumors. There are three isoforms, PLGF-1, PLGF-2, and PLGF-3. PLGF-2 is expressed up until week 8 in the placenta; the placental tissues continuously express PLGF-1 and PLGF-3 but only PLGF-1 is found in colon and mammary carcinomas. PLGF acts to stimulate angiogenesis, endothelial growth and migration. PLGF is a powerful promoter of tumor growth and is upregulated in some cancers, and PLGF is thought to aid in atherosclerotic lesions and neovascular growth surrounding the lesion. Also, PLGF appears to aid aldosterone mediated atherosclerosis. Serum levels of PLGF in some cases are used as a potential biomarker for disease or genetic defect. Recent research indicates that PLGF levels are lower in mothers with Down syndrome fetuses. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor
V3161SAF-100UG 100 ug
EUR 349.3
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include Fibroblast Growth Factor (FGF), Platelet Derived Growth Factor (PDGF), Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PLGF). Placenta growth factor (PLGF) is a secreted protein primarily produced by placental trophoblasts but also expressed in other endothelial cells and tumors. There are three isoforms, PLGF-1, PLGF-2, and PLGF-3. PLGF-2 is expressed up until week 8 in the placenta; the placental tissues continuously express PLGF-1 and PLGF-3 but only PLGF-1 is found in colon and mammary carcinomas. PLGF acts to stimulate angiogenesis, endothelial growth and migration. PLGF is a powerful promoter of tumor growth and is upregulated in some cancers, and PLGF is thought to aid in atherosclerotic lesions and neovascular growth surrounding the lesion. Also, PLGF appears to aid aldosterone mediated atherosclerosis. Serum levels of PLGF in some cases are used as a potential biomarker for disease or genetic defect. Recent research indicates that PLGF levels are lower in mothers with Down syndrome fetuses. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor
V2223-100UG 100 ug
EUR 349.3
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include fibroblast-, platelet derived-, vascular endothelial- and placenta- growth factor (PLGF). Like vascular endothelial growth factor, several PLGF variants have been shown to arise from alternative mRNA splicings. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor
V2223-20UG 20 ug
EUR 153.3
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include fibroblast-, platelet derived-, vascular endothelial- and placenta- growth factor (PLGF). Like vascular endothelial growth factor, several PLGF variants have been shown to arise from alternative mRNA splicings. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor
V2223SAF-100UG 100 ug
EUR 349.3
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include fibroblast-, platelet derived-, vascular endothelial- and placenta- growth factor (PLGF). Like vascular endothelial growth factor, several PLGF variants have been shown to arise from alternative mRNA splicings. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

Human PLGF ELISA kit (4X96T)
LF-EK50334 4×96T
EUR 2641.2

Placenta Growth Factor (PLGF) Antibody (FITC)
20-abx271259
  • EUR 393.60
  • EUR 260.40
  • EUR 1111.20
  • EUR 560.40
  • EUR 343.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Growth Factor (PLGF) Antibody (Biotin)
20-abx271525
  • EUR 393.60
  • EUR 260.40
  • EUR 1045.20
  • EUR 543.60
  • EUR 326.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human PLGF PicoKine ELISA Kit
EK0490 96 wells
EUR 523.2
Description: For quantitative detection of human PLGF in cell culture supernates, serum, plasma(heparin, EDTA, citrate) and urine.
The outcomes recommend that there’s a must develop further monoclonal antibodies that aren’t affected by the present spike protein mutations.
Antibodies where obtained from Orla Proteins Ltd. London.
Tags :  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *